Guardant Health Finds $50M
Redwood City-based Guardant Health, a developer of genome-based, cancer screening tests, said Tuesday that it has raised $50M in its Series C funding round. The funding was led by Lightspeed Venture Partners, and also included Formation 8, Khosla Ventures, and Sequoia Capital. The company says it has now raised a total of $100M. The company develops a cancer test which does not require a biopsy.
posted on Wednesday, February 4, 2015 (Link to more information)
Related companies:
Guardant Health, Inc.
Related stories:
> Guardant Health Gets $360M
> Guardant Health Snags $30M For Tumor Sequencing
> Guardant Health Gains $100M
> Limelight Health Finds $3M
> Omada Health Finds $48M
silicontap.com Home